In a preclinical study, it has been shown that olanzapine treatment elevates hypothalamic ghrelin receptor expression in rats (166, 167), supporting that ghrelin signaling plays a role in APD-induced obesity. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.